HAB Pharma Announces Major Expansion with Two New Plants
HAB Pharma announces a significant expansion with two new manufacturing plants—one dedicated to metered dose inhalers and another for large-volume tablets. This strategic expansion demonstrates HAB Pharma\'s commitment to meeting the growing demands of the global pharmaceutical market. As a leading Indian pharmaceutical company, HAB Pharma continues to strengthen its manufacturing capabilities and product portfolio. The expansion reflects the company\'s dedication to innovation and quality, with state-of-the-art facilities designed to support production excellence. This move positions HAB Pharma as a key player in the pharmaceutical sector, enabling the company to serve healthcare providers and patients more effectively across multiple therapeutic areas and geographic regions.